Uzbekistan may start production of drug to treat COVID-19

AKIPRESS.COM - Medical drug Covipir for treatment of COVID-19 is likely to be produced in Uzbekistan, Kun.uz reports.
Nobel Pharmsanoat started state registration of the drug which contains active substance favipiravir, advisor of Minister of Innovational Development Isajon Sultonov stated.
According to quality director of the company Shamshod Sharipov, the drug was patented by Japanese company Toyama Chemical.
"It has been proved that the drug possesses a wide spectrum of antagonism for viruses with RNA (flu, rhinovirus, respiratory viruses) and has positive anticoronavirus effect. The drug has been used in Japan to treat patients with coronavirus since February. China's Zhejiang Hisun Pharmaceutical started producing drug under mark Favilavir this month. HimRar and Russian investment foundation will start production of Avifavir in May," Sharipov said.
Medical drug Covipir will be produced for Uzbekistan's needs in the first place.